Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × FED × Lymphoid × Clear all

Phase

Phase 2 4 Phase NA 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 1 1

Status

Sponsor Class

OTHER 125 INDUSTRY 45 OTHER_GOV 8 NETWORK 4 UNKNOWN 1 NIH 1 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6 Other hematologic neoplasm 1 Lymphoid 1 Genitourinary 1 Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Anxiety Disorders 1

Interventions

Midazolam 1 Ketamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03043430 2023-04-25

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Brooke Army Medical Center

Phase 4 Terminated

LymphoidOther hematologic neoplasm

Anxiety Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡